The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
Open accessAbstract
Although the precise pathogenesis of schizophrenia is unknown, genetic, biomarker and imaging studies suggest involvement of the immune system. In this study, we performed a systematic review and meta-analysis of studies investigating factors related to the immune system in postmortem brains of schizophrenia patients and healthy controls. Forty-one studies were included, reporting on 783 patients and 762 controls. We divided these studies into those investigating histological alterations of cellular composition and those assessing molecular parameters; meta-analyses were performed on both categories. Our pooled estimate on cellular level showed a significant increase in the density of microglia (P=0.0028) in the brains of schizophrenia patients compared with controls, albeit with substantial heterogeneity between studies. Meta-regression on brain regions demonstrated this increase was most consistently observed in the temporal cortex. Densities of macroglia (astrocytes and oligodendrocytes) did not differ significantly between schizophrenia patients and healthy controls. The results of postmortem histology are paralleled on the molecular level, where we observed an overall increase in expression of proinflammatory genes on transcript and protein level (P=0.0052) in patients, while anti-inflammatory gene expression levels were not different between schizophrenia and controls. The results of this meta-analysis strengthen the hypothesis that components of the immune system are involved in the pathogenesis of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rao, J. S., Kim, H.-W., Harry, G. J., Rapoport, S. I., & Reese, E. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.017 · Cited by 106
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
(2000) · Cited by 9,198
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
The microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
for the ENIGMA Schizophrenia Working Group, van Erp, T. G. M., Hibar, D. P., Rasmussen, J. M., Glahn, D. C., Pearlson, G. D., Andreassen, O. A., Agartz, I., Westlye, L. T., Haukvik, U. K., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.63 · Cited by 1,135
Self-citationMitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,082
Methodological issues and advances in biological meta-analysis
Nakagawa, S., & Santos, E. S. A. (2012) · Evolutionary Ecology · doi:10.1007/s10682-012-9555-5 · Cited by 1,032
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917
Self-citationDifferential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846
Functional requirement for class I MHC in CNS development and plasticity
Huh, G. S., Boulanger, L. M., Du, H., Riquelme, P. A., Brotz, T. M., & Shatz, C. J. (2000) · Science · doi:10.1126/science.290.5499.2155 · Cited by 828
Review: microglia of the aged brain: primed to be activated and resistant to regulation
Norden, D. M., & Godbout, J. P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01306.x · Cited by 792
Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Calcia, M. A., Bonsall, D. R., Bloomfield, P. S., Selvaraj, S., Barichello, T., & Howes, O. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4218-9 · Cited by 709
Fillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582
van Berckel, B. N., Bossong, M. G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582
Self-citationNeuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R. A., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 559
Fixed effects and variance components estimation in three-level meta-analysis
Konstantopoulos, S. (2011) · Research Synthesis Methods · doi:10.1002/jrsm.35 · Cited by 521
Antibodies to Toxoplasma gondii in Patients With Schizophrenia: A Meta-Analysis
Torrey, E. F., Bartko, J. J., Lun, Z.-R., & Yolken, R. H. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl050 · Cited by 503
Bloomfield, P. S., Selvaraj, S., Veronese, M., Rizzo, G., Bertoldo, A., Owen, D. R., Bloomfield, M. A. P., Bonoldi, I., Kalk, N., Turkheimer, F., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101358 · Cited by 443
Maes, M., Bosmans, E., Calabrese, J., Smith, R., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
MHC Class I: An Unexpected Role in Neuronal Plasticity
Shatz, C. J. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.044 · Cited by 372
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.90 · Cited by 360
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Sommer, I. E., van Westrhenen, R., Begemann, M. J. H., de Witte, L. D., Leucht, S., & Kahn, R. S. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt139 · Cited by 342
Self-citationNeuroinflammation in schizophrenia especially focused on the role of microglia
Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314
Astrogliosis in CNS Pathologies: Is There A Role for Microglia?
Zhang, D., Hu, X., Qian, L., O’Callaghan, J. P., & Hong, J.-S. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8098-4 · Cited by 298
Fillman, S. G., Weickert, T. W., Lenroot, R. K., Catts, S. V., Bruggemann, J. M., Catts, V. S., & Weickert, C. S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.90 · Cited by 270
Fillman, S. G., Sinclair, D., Fung, S. J., Webster, M. J., & Shannon Weickert, C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.8 · Cited by 226
Molecular profiles of schizophrenia in the CNS at different stages of illness
Narayan, S., Tang, B., Head, S. R., Gilmartin, T. J., Sutcliffe, J. G., Dean, B., & Thomas, E. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.023 · Cited by 207
Busse, S., Busse, M., Schiltz, K., Bielau, H., Gos, T., Brisch, R., Mawrin, C., Schmitt, A., Jordan, W., Müller, U. J., et al. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.08.005 · Cited by 194
de Witte, L., Tomasik, J., Schwarz, E., Guest, P. C., Rahmoune, H., Kahn, R. S., & Bahn, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.005 · Cited by 188
Self-citationActivation of brain interleukin-1β in schizophrenia
Söderlund, J., Schröder, J., Nordin, C., Samuelsson, M., Walther-Jallow, L., Karlsson, H., Erhardt, S., & Engberg, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.52 · Cited by 179
In vivo immunomodulatory effects of clozapine in schizophrenia
Maes, M., Bosmans, E., Kenis, G., De Jong, R., Smith, R. S., & Meltzer, H. Y. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00057-1 · Cited by 178
Brain Temperature: Physiology and Pathophysiology after Brain Injury
Mrozek, S., Vardon, F., & Geeraerts, T. (2012) · Anesthesiology Research and Practice · doi:10.1155/2012/989487 · Cited by 177
Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system
Schafer, D. P., & Stevens, B. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.09.012 · Cited by 174
Kenk, M., Selvanathan, T., Rao, N., Suridjan, I., Rusjan, P., Remington, G., Meyer, J. H., Wilson, A. A., Houle, S., & Mizrahi, R. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu157 · Cited by 169
Coughlin, J. M., Wang, Y., Ambinder, E. B., Ward, R. E., Minn, I., Vranesic, M., Kim, P. K., Ford, C. N., Higgs, C., Hayes, L. N., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.40 · Cited by 169
Stereologic investigation of the posterior part of the hippocampus in schizophrenia
Schmitt, A., Steyskal, C., Bernstein, H.-G., Schneider-Axmann, T., Parlapani, E., Schaeffer, E. L., Gattaz, W. F., Bogerts, B., Schmitz, C., & Falkai, P. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0430-y · Cited by 167
Self-citationIncreased expression of astrocyte markers in schizophrenia: Association with neuroinflammation
Catts, V. S., Wong, J., Fillman, S. G., Fung, S. J., & Weickert, C. S. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414531078 · Cited by 148
Reproducibility and Correlations of Multiplex Cytokine Levels in Asymptomatic Persons
Wong, H., Pfeiffer, R. M., Fears, T. R., Vermeulen, R. C. H., Ji, S., & Rabkin, C. S. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0311 · Cited by 147
The metabolic syndrome in schizophrenia: is inflammation a contributing cause?
Leonard, B. E., Schwarz, M., & Myint, A.-M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431622 · Cited by 141
Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia
Volk, D. W., Chitrapu, A., Edelson, J. R., Roman, K. M., Moroco, A. E., & Lewis, D. A. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15010019 · Cited by 138
Pasternak, O., Westin, C., Dahlben, B., Sylvain Bouix, A., & Kubicki, M. R. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.031 · Cited by 136
Major Histocompatibility Complex I in Brain Development and Schizophrenia
McAllister, A. K. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.003 · Cited by 131
Kowalski, J., Blada, P., Kucia, K. A., Madej, A., & Herman, Z. S. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00156-0 · Cited by 128
Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA
Hafizi, S., Tseng, H.-H., Rao, N.-R. P., Selvanathan, T., Kenk, M., Bazinet, R., Suridjan, I., Wilson, A., Meyer, J., Remington, G., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16020171 · Cited by 127
Golub, R., & Cumano, A. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.08.004 · Cited by 124
Wierzba‐Bobrowicz, T., Lewandowska, E., Lechowicz, W., Stępień, T., & Pasennik, E. (2005) · PubMed · Cited by 113
Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis
Papazova, D. A., Oosterhuis, N. R., Gremmels, H., van Koppen, A., Joles, J. A., & Verhaar, M. C. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017699 · Cited by 107
Self-citationInflammatory Molecular Signature Associated With Infectious Agents in Psychosis
Hayes, L. N., Severance, E. G., Leek, J. T., Gressitt, K. L., Rohleder, C., Coughlin, J. M., Leweke, F. M., Yolken, R. H., & Sawa, A. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu052 · Cited by 106
Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia
Kubota, M., van Haren, N. E. M., Haijma, S. V., Schnack, H. G., Cahn, W., Pol, H. E. H., & Kahn, R. S. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0712 · Cited by 102
Self-citationAn optimized protocol for the acute isolation of human microglia from autopsy brain samples
Olah, M., Raj, D. D. A., Brouwer, N., Haas, A. H. D., Eggen, B. J. L., den Dunnen, W. F. A., Biber, K. P. H., & Boddeke, H. W. G. M. (2011) · Glia · doi:10.1002/glia.21251 · Cited by 84
Notes from the graveyard: neuropathology and schizophrenia*
Roberts, G. W., & Bruton, C. J. (1990) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1990.tb00927.x · Cited by 77
Xu, M., & He, L. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1031 · Cited by 69
In vivo (R)-[11C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis
van der Doef, T. F., de Witte, L. D., Sutterland, A. L., Jobse, E., Yaqub, M. M., Boellaard, R., de Haan, L., Eriksson, J., Lammertsma, A. A., Kahn, R. S., et al. (2016) · Schizophrenia · doi:10.1038/npjschz.2016.31 · Cited by 69
Self-citationIncreased interleukin-1 and interleukin-3 like activity in schizophrenic patients
Sirota, P. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00106-r · Cited by 64
Kuehne, L. K., Reiber, H., Bechter, K., Hagberg, L., & Fuchs, D. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.027 · Cited by 62
Toyooka, K., Watanabe, Y., Iritani, S., Shimizu, E., Iyo, M., Nakamura, R., Asama, K., Makifuchi, T., Kakita, A., Takahashi, H., et al. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00093-2 · Cited by 55
F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma
Pong, W. W., Walker, J., Wylie, T., Magrini, V. J., Luo, J. R., Emnett, R. J., Choi, J., Cooper, M. L., Griffith, M., Griffith, O. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077571 · Cited by 50
The Neurophysiology of Auditory Hallucinations – A Historical and Contemporary Review
van Lutterveld, R., Sommer, I. E., & Ford, J. M. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00028 · Cited by 50
Self-citationEstimating the prevalence of schizophrenia in Spain using a disease model
Ayuso‐Mateos, J. L., Gutiérrez-Recacha, P., Haro, J. M., & Chisholm, D. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.003 · Cited by 48
Bernstein, H., Hildebrandt, J., Dobrowolny, H., Steiner, J., Bogerts, B., & Pahnke, J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.036 · Cited by 35
Glucocorticosteroids Associated With a Decreased Risk of Psychosis
Laan, W., Smeets, H. M., de Wit, N. J., Kahn, R. S., Grobbee, D. E., & Burger, H. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a44575 · Cited by 34
Self-citationKano, S., Nwulia, E. A., Niwa, M., Chen, Y., Sawa, A., & Cascella, N. G. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.1818 · Cited by 32
Non-steroidal anti-inflammatory drugs and the risk of psychosis
Laan, W., Selten, J., Grobbee, D. E., Smeets, H. M., Kahn, R. S., & Burger, H. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.09.003 · Cited by 17
Self-citationIntroduction to the Special Section
Maes, M. H. J. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003036 · Cited by 15
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Nonsocial and social cognition in schizophrenia: current evidence and future directions
Green, M. F., Horan, W. P., & Lee, J. (2019) · World Psychiatry · doi:10.1002/wps.20624 · Cited by 612
Microbiome–microglia connections via the gut–brain axis
Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471
Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies
Marques, T. R., Ashok, A. H., Pillinger, T., Veronese, M., Turkheimer, F. E., Dazzan, P., Sommer, I. E. C., & Howes, O. D. (2019) · Psychological Medicine · doi:10.1017/s0033291718003057 · Cited by 213
Self-citationTSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward
Guilarte, T. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.003 · Cited by 173
Metadata
- Authors
- van Kesteren, C. F. M. G., Gremmels, H., de Witte, L. D., Hol, E. M., Van Gool, A. R., Falkai, P. G., Kahn, R. S., & Sommer, I. E. C.
- Venue
- Translational Psychiatry
- Published
- 2017-03-28
- Volume
- 7
- Issue
- 3
- Pages
- e1075-e1075
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W2600498303
- Cited by
- 368
- References
- 85
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.